GYRE
Gyre Therapeutics Inc

9,465
Mkt Cap
$748.94M
Volume
80,999.00
52W High
$13.75
52W Low
$6.11
PE Ratio
216.27
GYRE Fundamentals
Price
$8.24
Prev Close
$8.52
Open
$8.49
50D MA
$7.77
Beta
1.36
Avg. Volume
81,747.85
EPS (Annual)
$0.0481
P/B
7.35
Rev/Employee
$21.15M
$1,247.76
Loading...
Loading...
News
all
press releases
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates
Day One Biopharmaceuticals (DAWN) delivered earnings and revenue surprises of -19.98% and +11.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
More News
News Placeholder
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Given Average Recommendation of "Hold" by Brokerages
Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) has received an average rating of "Hold" from the five brokerages that are presently covering the firm, MarketBeat reports. One analyst has...
MarketBeat·7d ago
News Placeholder
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of "Hold" from Brokerages
Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) have earned a consensus rating of "Hold" from the five brokerages that are currently covering the company, MarketBeat Ratings...
MarketBeat·1mo ago
News Placeholder
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.7% - Time to Sell?
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.7% - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Should You Buy?
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Time to Buy...
MarketBeat·2mo ago
News Placeholder
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday
read more...
Benzinga·2mo ago
News Placeholder
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Given Average Rating of "Hold" by Analysts
Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) have earned an average recommendation of "Hold" from the five ratings firms that are currently covering the stock, Marketbeat...
MarketBeat·2mo ago
News Placeholder
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.6% - Time to Sell?
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.6% - What's Next...
MarketBeat·2mo ago
News Placeholder
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 5.9% - Should You Sell?
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 5.9% - What's Next...
MarketBeat·3mo ago
News Placeholder
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 2.3% - Time to Buy?
Gyre Therapeutics (NASDAQ:GYRE) Trading 2.3% Higher - Still a Buy...
MarketBeat·3mo ago
<
1
2
...
>

Latest GYRE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.